Our aim is to assess the subfield-specific histopathological correlates of hippocampal volume and intensity changes (T1, T2) as well as diffusion MRI markers in TLE, and investigate the efficacy of quantitative MRI measures in predicting histopathology in vivo. We correlated in vivo volumetry, T2 signal, quantitative T1 mapping, as well as diffusion MRI parameters with histological features of hippocampal sclerosis in a subfield-specific manner. We made use of on an advanced co-registration pipeline that provided a seamless integration of preoperative 3T MRI with post-operative histopathological data, on which metrics of cell loss and gliosis were quantitatively assessed in CA1, CA2/3, and CA4/DG. MRI volumes across all subfields were positively correlated with neuronal density and size. Higher T2 intensity related to increased GFAP fraction in CA1, while quantitative T1 and diffusion MRI parameters showed negative correlations with neuronal density and/or size in CA4/DG/. Subfield-based multiple linear regression analysis revealed that in vivo multi-parametric MRI can predict neuronal loss in all subfields with up to 97% accuracy. Our results, based on an accurate co-registration pipeline and a subfield-specific analysis of MRI and histology, demonstrate the potential of MRI volumetry, diffusion, and quantitative T1 as accurate in vivo biomarkers of hippocampal subfield pathology.
Introduction
Temporal lobe epilepsy (TLE) is the most common form of drug-resistant epilepsy in adults 1 .
Hippocampal sclerosis (HS) is the histopathological hallmark of TLE and the most common underlying etiology 2 . It is characterized by cell loss and gliosis in the hippocampal formation, with substantial individual variability in the extent and spatial distribution of these changes.
Since early pathological descriptions 3 , it has been widely accepted that subfields such as Cornu Ammonis (CA) 1, CA3, CA4, and the dentate gyrus present with marked changes, while CA2 is relatively spared 4 . Across patients, HS encompasses a broad spectrum of structural changes, which can be categorized into different subtypes based on neuropathological grading systems [5] [6] [7] .
Previous findings have suggested an association between histopathological subtypes, postsurgical seizure outcomes, and postoperative memory impairment [6] [7] [8] [9] . In-vivo prediction of distinct subfield atrophy may lead to more accurate TLE diagnosis and improved patient management. It may also play an important role in the early detection and treatment of other neurological and neurodegenerative diseases, such as Alzheimer's disease (West, 2004) , stress (McEwen, 1997) or schizophrenia (Harrison, 2004) , where the subfields are selectively affected.
MRI has played a key role in the pre-surgical evaluation of TLE, with in-vivo volumetry and T2-MRI showing a high utility in identifying HS [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Landmark studies have shown that global hippocampal atrophy correlates with pathological grades of hippocampal cell loss 10 ; and that T2 signal mainly relates to glial cell count, particularly in the dentate gyrus 19 . While these studies represent important steps towards a histopathological validation of MRI markers of HS, assessments have been carried out either on the whole hippocampus or have been restricted to single subfields. Moreover, comparisons between the resected tissue and MRI did not employ rigorous data co-registration that would allow for a regionally specific correlation between invivo MRI and histological features. Finally, although previous reports have suggested that diffusion assessments may be a sensitive marker of HS-related changes 21 , the exact histopathological correlate of abnormal diffusion in TLE has not been established in humans.
The current study aims to assess the subfield-specific histopathological correlates of an ensemble of advanced MRI markers. Specifically, we evaluated hippocampal volume, T2
intensity, quantitative T1 and diffusion MRI markers in TLE, and investigated their efficacy in predicting histopathology in vivo. Our analysis framework is built on a unique co-registration pipeline that allows for seamless integration of preoperative high-resolution MRI with postoperative histopathological data, on which metrics of cell loss and gliosis were quantitatively assessed.
Materials and methods

Patients and Samples
The subjects in this study were 15 patients with drug-resistant TLE (7 males and 8 females, age=36±12 years, range=20-59 years), who underwent anterior temporal lobectomy (ATL) with amygdalohippocampectomy surgery at the London Health Sciences Centre. The hippocampal specimens were resected en-bloc by two surgeons at our centre, with minimal use of ultrasonic aspiration. All subjects underwent preoperative 1.5 Tesla clinical MRI (acquiring T1-weighted, T2-weighted, FLAIR, and diffusion-weighted sequences) and neuropsychological testing, as part of their pre-surgical evaluation. Video-scalp EEG telemetry was employed to identify the epileptogenic zone, with four patients needing subdural electrode placement to better localize their seizures onset zone. In addition to the 1.5 T conventional MRI sequences, subjects underwent a series of scans on a 3.0 T research scanner as described in the in-vivo MRI imaging subsection. Table 1 summarizes the clinical and demographic information for our cohort. Fifteen subjects were originally recruited, however two were discarded from the analysis as the hippocampi were fragmented, and there was insufficient tissue to clinically assess HS or perform automated neuron analysis. Informed consent was collected from all participants prior to their recruitment in the study. This project was approved by the office of Research Ethics of Western University.
MRI acquisition a) In-vivo acquisition
All patients underwent in vivo imaging on a 3.0 T Discovery MR750 scanner (General Electric, Milwaukee, WI, USA) using a 32 channel head coil. The DESPOT1-HIFI technique 22 
MRI processing a) Quantitative T1
The T1-weighted volumes co-registered to the first image volume of the session using a rigid transformation obtained with FLIRT (FSL 4.1, http://fsl.fmrib.ox.ac.uk). Quantitative T1 maps were reconstructed using the approach described by Deoni et al. 22 .
b) Diffusion MRI
Non-linear distortions were corrected by deformable registration of the average unweighted volume to the undistorted T1 map using a diffeomorphic registration method 23, 24 . FMRIB's Diffusion Toolbox (FDT) was used for motion and eddy current correction and estimation of the diffusion tensor. In addition, we computed the two diffusion tensor imaging (DTI) parameters;
fractional anisotropy (FA) and mean diffusivity (MD), also known as apparent diffusion coefficient (ADC), which are the most commonly used indices in the epilepsy literature, defined as:
where
1 , 2 , 3 are the eigenvalues of the diffusion tensor. Using linear registration (FLIRT), we transformed and resampled the resulting diffusion maps to the coordinate system defined by T1 map (1 mm isotropic voxel size). We quantified NeuN using field fraction estimates (i.e., the proportion of pixels in the field that are positively-stained). These estimates are sensitive to the packing density and cellsize of neuronal cell bodies and processes and have been previously employed to represent neuronal integrity [25] [26] [27] . Similarly, we quantified field fraction estimates of GFAP IHC, which is sensitive to reactive astrogliosis and analyzed the full resolution slides in blocks of 100x100 um using MATLAB (The MathWorks Inc., Natick, MA, USA). To provide local estimates of neuron density and size we developed a method for segmenting cell bodies of pyramidal and granular neurons. This technique first extracts the colour component related to immuno-positive staining using colour deconvolution 28 preceding a watershed-based segmentation procedure 29 for splitting joined or connected neurons, and removes objects smaller than a predefined area defined as noise (less than 14 μm 2 ). Resulting neuron segmentations provide the neuronal density (number of neurons) per field, as well as the mean area (size) of cell bodies, within the field. To further discriminate between pyramidal neurons of the CA subfields and granular neurons of the dentate gyrus, we used area thresholds (125 and 50 µm 2 respectively). Neuron-specific quantitative features in each field of these images were extracted using a custom algorithm written in MATLAB. Manual counts taken from two randomly selected fields per slice within the CA subfields and the dentate gyrus by one rater (blinded to the automated counts) were employed to validate our automated cell segmentation for pyramidal and granular neuron quantification. Automated (A) and manual (M) segmentation achieved a high agreement Kappa 
Quantitative histology
Histology feature extraction
A single rater (MG) manually delineated hippocampal subfields on histology slices, downsampled to 20µm pixel size using ITKSNAP 30 , and were confirmed by neuropathologist (RH). Our segmentation protocol is based on the Duvernoy hippocampus atlas 31 , with the following boundary definitions: The border between the subiculum and CA1 was defined as a horizontal line at the edge of the subiculum extending from the inferior border of the dentate gyrus and the hippocampal sulcus, as shown in the top row of Figure 2 . The CA1/CA2 boundary was designated as the point at which a noticeable decrease in width of the CA1 subfield was observed, following the most lateral point of the DG. The CA2/CA3 boundary was defined at the most medial point of the superior curve of the dentate gyrus where a gradient of pyramidal cell density is observed between the subfields. The opening of subfields into the globular region of the hippocampal formation formed the CA3/CA4 border. The remaining globular region of the hippocampal formation was marked as CA4. The dentate gyrus was divided into two labels, one encompassing the granular layer and another combining both molecular and polymorphic layers surrounding the granular cells. Figure 2 shows examples of subfield delineation on histology slices from three patients from our cohort with mild, moderate and severe sclerosis.
MRI parameter extraction
We first applied our previously described MRI to histology 32, 33 registration pipeline, which allowed for the identification of the MRI slice that best corresponded to the cut histology slice (Figure 3) . Instead of relying on imaging parameters from segmented subfields along the entire length of the hippocampus, parameters can be analyzed from a select target region encompassing the MRI slice corresponding to a given histological slice. For more robust correlations, we modelled uncertainty stemming from registration (approx. 2.5 mm) 32, 33 and histological sectioning errors (variance in sectioning histology slices from the face of blocks, approx. 1 mm) 34 . Specifically, MRI data adjacent to the corresponding slice were cropped and weighted using a sinc function with FWHM=3mm, giving data adjacent to the closest corresponding MRI slice in the sagittal plane a higher weighting than those more distant.
Within a given target region, subfields were then manually segmented by a single rater (MG). This segmentation protocol mirrors that employed on histology and is similar to that described in our previous work at 7.0 T 35 . The MRI protocol was confirmed by consensus with a neurologist (NB) and a neuropathologist (RH). Assessment was restricted to CA1, CA2/3, and CA4/DG. It should be noted that MRI parameter extraction was performed in the intrinsic in vivo space (1 mm isotropic) and not the upsampled space to avoid resampling the quantitative maps.
Statistical analysis
Statistical analyses were performed using SPSS statistics (version 20, IBM, Armonk, NY) and JMP statistical software (version 10, SAS, Cary, NC). Prior to analysis, MRI parameters and histological features were internally z-scored. It should be noted that DTI measures were only assessed in CA1 and CA4/DG in the subfield-specific analysis, due to the lower native resolution of the diffusion MRI acquisition. The statistical analysis was stratified into four distinct experiments:
A. MRI-histology correlations i. Univariate correlation analysis
We systematically assessed pair-wise, non-parametric (Spearman Rho) correlations between individual histological parameters relating to neuronal characteristics (neuronal size and density) and putative MRI markers of neuronal loss (subfield volume and T1 intensity 36 ). In a second step, we evaluated correlations between histological GFAP field fraction and MRI-derived T2-w intensity. In a more exploratory diffusion-histology assessment, we correlated histological parameters with FA and MD. Multiple comparisons were corrected at a family-wise error (FWE) of p < 0.05 using non-parametric permutation tests 37 . Permutation tests were performed in MATLAB based on two-tailed Spearman rank correlations with 100,000 random permutations. The family-wise error corrected p-values (alpha=0.05) for each comparison were obtained using the distribution of the most extreme statistic calculated for each permutation.
ii. Multiple linear regressions.
To test the efficacy of quantitative, multi-parametric MRI in pre-operatively predicting neuronal loss per subfield, multiple linear regression analyses were performed between a) subfieldspecific MRI parameters and percent loss of neurons for each subfield, b) MRI parameters from all subfields and percent neuronal loss for each subfield.
B. Clinical correlations
In addition, we assessed the correlations between each of the above variables and clinical variables such as age of seizure onset, duration of epilepsy and short-term Engel seizure outcome.
C. Validation Experiments
We performed three experiments to validate our in-vivo DTI measurements and provide further evidence that our correlation analysis is not driven by single outliers or confounds such as the partial volume effect.
i.
High-resolution ex-vivo DTI
This experiment was performed with the aim of validating our in-vivo DTI measurements with higher resolution ex-vivo data. We first employed our registration pipeline to obtain a mapping between ex-vivo data and histology then warped the histology labels to the ex-vivo space. These labels were then used to initialize the segmentation and to define the ex-vivo corresponding slices. Segmentation adjustments were applied by the same rater (if needed post-registration) on T2-weighted structural images, prior to extraction of diffusion parameters from FA and MD maps and comparison with in-vivo measurements. Voxels at the gray matter-CSF boundary (in CA1 and CA2) were not segmented to avoid CSF contamination in our validation datasets.
Correlation coefficients were computed between both scanning sessions for both diffusion parameters.
ii. Label Erosion
In addition, we eroded the subfield segmentation labels inward and repeated all the univariate correlation analysis as a further demonstration that partial volume effects did not influence our results.
iii. Bootstrapping
We employed the bootstrapping technique, with a sample size of 1000 and 95% bias corrected confidence intervals on all the tested correlations, to better estimate the confidence intervals of the presented correlation coefficients and ensure the reliability of our results. We will present the results of this experiment alongside the univariate correlation results, where each correlation coefficient is followed by its 95% bias corrected lower and upper confidence intervals from bootstrapping.
Results
A. MRI-histology correlations i. Univariate correlations (Table 2 and Figure 4).
Across all subfields, we observed a consistent positive correlation between MRI-derived subfield volume and histology-derived neuronal density and size, with highest effect sizes in CA1 The model fit for the prediction of neuronal loss of the four analyzed subfields from subfieldspecific parameters is presented in Figure 5 .
B. Clinical correlations
In the subfield-specific correlation analysis, only CA2/3 T1 negatively correlated with short-term were not included in this analysis due to their relatively smaller size compared to our in-vivo DTI voxel size.
ii. Label erosion
Findings remained highly significant even when subfield labels were eroded prior to analysis as described earlier, suggesting minimal confounds due to partial volume effect (Suppl. Table 1 ).
Discussion
This is the first study to investigate the histopathological substrates of volume, T2, quantitative T1 relaxometry while employing high resolution maps at 3.0 T and a comprehensive mapping between MRI and pathology. A number of studies previously correlated T2 and volumetry with pathology in the context of hippocampal sclerosis [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, they only focused on whole hippocampus MRI parameters or correlated pathology findings on a histology slice with subfield parameters extracted from the entire hippocampus or employed in vivo scans with low out-of-plane resolution (> 3 mm) and no registration was preformed to establish correspondences between MRI and histology 12-15, 17, 18 . Although previous studies investigated diffusion changes in patients with HS and demonstrated increased MD as well as decreased FA in the ipsilateral hippocampi and white matter [38] [39] [40] [41] [42] , this is the first to investigate histopathological correlates of diffusion metrics in TLE within the hippocampal subfields. Our registration protocol validates our high-resolution MRI maps with quantitative histology to better understand the pathological substrates of our imaging findings. These features may be more sensitive to neuronal degeneration as distinct from qualitative assessment or quantitative grading of neuronal loss as they provide a continuous measurement of pathologies.
Biological Interpretations
In our correlation analysis, pre-operative subfield volumetry was highly correlated with subfield density (specifically in CA1). Numerous studies have reported that neuronal density within the subfield may directly relate to volume atrophy 10, 11, 13, 19, 20 . The presented subfield-specific correlation analyses confirmed these previous findings.
Mean diffusivity was the most prominent MRI marker, other than volume, for neuronal density. In our subfield-specific analysis, MD was negatively correlated with neuronal density and size of CA4, demonstrating the importance of this MRI parameter in determining subtypes pre-operatively. A previous study analyzing relationships between diffusion maps and cell density in malignant brain tumours described an analogous association between MD and tumour core cell density 43 . The loss of neurons in the hippocampal subfields may lead to less restricted, water diffusion and thus higher diffusivity. A similar interpretation can be described for the relationship between MD and neuronal size: as neuronal cell bodies shrink, the proportion of intra-neuronal water is reduced thereby increasing diffusivity. Given the limitations of in-vivo DTI, we cannot precisely assess the nature of the architectural changes related to MD, but we hope to explore these issues further using high-resolution ex-vivo DTI of the resected specimens.
It has been suggested 19 that in-vivo T2 relaxation relates to dentate glial cell count, whereas a more recent study found no correlation between ex-vivo T2-w and GFAP field fraction in the subfields 44 . In our results, T2 also correlated with increased GFAP field fraction expression in CA1, which represents reactive gliosis (astrocytic and microglial proliferation), but failed to show a significant correlation in the dentate gyrus. T1 was correlated as well with neuronal size/density in CA4. An analogous relationship between ex-vivo GM T1 values and neuronal density has been previously described in patients with multiple sclerosis 45 . Cell loss will likely result in an increase in the extra-cellular space, thus the intra-cellular water will decrease as extra-cellular water increases, which in turn would increase T1 46 . The presence of a significant association between T1 and neuronal markers in CA4/DG may be due to the high content of zinc in the mossy fiber projections from the dentate gyrus 47 . Our previous study 36 
Clinical findings and insights
Multiple linear regression analysis revealed that volume and MD are the most prominent parameters in predicting neuronal loss, with increased accuracy when adding T2. This observation mirrors the correlation analysis where MD and volume were the parameters with the highest number of associations with histological features. T2 was correlated with GFAP field fraction in CA1 whereas MD was correlated with density in CA4, while both have similar insignificant trends in other subfields. A larger cohort may be needed to observe their predictive ability in other subfields. Hippocampal neuronal loss has been previously shown to potentially predict patient outcomes 48 and memory deficits 49 . Predicting subfield loss from in vivo quantitative MRI has the potential to non-invasively localize pathology and determine the extent of hippocampal atrophy, with a precision previously unachievable. It may also help classify patients into different HS subtypes and decide on the merit of their surgical candidacy.
Moreover, it may help identify select hippocampal subfields for targeting electrodes used for neurostimulation therapy or MRI-guided laser ablation, as an alternative to resective surgical intervention.
The association between the qualitative HS subtype classification and neuronal density within the CA subfields, validates the accuracy of our automated neuron quantification procedure. Some reports have previously shown that hippocampal sclerosis subtypes have different post-operative outcomes 8, 9 , and correlate with seizure duration and onset 50 . The Engel outcomes presented in this study are reported in the short-term follow up with the average time since surgery for our cohort being just under two years (22 months). CA2/3 T1 was the only invivo MRI parameter to correlate with outcomes in our cohort, which mirrors the classification results demonstrating CA2's ability to represent the spectrum of atrophy across patients.
Limitations and technical considerations
A limitation of this work is the lack of normative control data for histology, and hence in our assessment, the least sclerotic specimens were used as reference for computation of percentage cell loss. We also employed histological measurements from one optimal slide per subject, which may have biased the results. This was due to the restricted size of the resected specimens (only a fraction of the hippocampus is resected at times) and the large variability in specimen sizes, as well as effects of tissue breakage and fragmentations. These limitations, in addition to the need to reserve part of the specimen in tissue banks for clinical use, restricted the analysis to a maximum of one histology slide (for some subjects) where all the CA subfields are clearly visible. In addition, we employed an approximation of T2 values using intensity-normalized T2-weighted images, as some failed T2-weighted acquisitions for an earlier subset of patients prevented us from computing DESPOT2 for all subjects. We opted to manually segment the subfields on MRI, instead of relying on an automated technique, which uses a statistical model with Markov random field priors to delineate subfield boundaries based on T1-weighted MPRAGE MR sequences 20 . Although this approach is more time consuming and possibly prone to rater-bias, it produces more accurate labels specifically in very sclerotic hippocampi, and those with malrotation where the image signal to noise, contrast and resolution, as well as morphology are not sufficient to guide the automated technique. Another way to correlate pre-operative MRI and pathology is through direct registration of both modalities 32 
Conclusion
This is the first study to investigate the histopathological substrates of in vivo volume, T2, (middle) and CA4 (right).
